| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.031 | 0.8 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.091 | 0.8 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |